Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR number# DK-1577272925-2016000880) on 08-FEB-2016. Case received from a physician via health authority on 04-FEB-2016 under reference number DK-DKMA-WBS-0002565. A 12-year-old female adolescent patient received GARDASIL, (batch number unknown, Dose 1) via intramuscular route on 24-OCT-2012, GARDASIL, (batch number unknown) on 21-NOV-2012, GARDASIL, (batch number unknown) via intramuscular route on 22-MAY-2013. The patient experienced headache in 2012, aggravation of back pain in 2012, aggravation of neck pain in 2012 and the patient has a declining function level. She performs less sport and need to sleep during the day on an unknown date. The patient has had neck and back pain since 2009, but the pains has got worse after vaccination with GARDASIL. In addition the patient has developed headache, which now was the dominant symptom. Onset 2012 and got worse during 2013. Now less. The patient has after the vaccination declining function level. She do less sport and need to sleep during the day. There offered admission in interdisciplinary courses at local pediatric department. Blood test all normal. Neurological and rheumatological examinations normal, terminated. Other medicine or vaccines: No. The patient hade a medical history of: Back pain in 2009 and Neck pain in 2009. The patient''s outcome was reported as Not Recovered/Not Resolved except for reduced general condition which was reported as unknown.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166